BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

  September 26, 2024

   · 

  7 min read
• Press Releases

  Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis

  September 26, 2024

   · 

  12 min read
• Press Releases

  Sensorion Announces Webconference for Retail Shareholders on October 10, 2024

  September 26, 2024

   · 

  3 min read
• Press Releases

  Breakthrough Therapy Designation (BTD) for BioCity’s SC0062, a selective endothelin type A (ETA) antagonist, granted by National Medical Products Administration for IgA nephropathy (IgAN) with proteinuria

  September 26, 2024

   · 

  4 min read
• Press Releases

  Enterprise Therapeutics Granted ‘Rare Pediatric Disease Designation’ in the US for Novel Cystic Fibrosis Investigational Therapy ETD001

  September 26, 2024

   · 

  2 min read
• Press Releases

  PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

  September 26, 2024

   · 

  8 min read
• Press Releases

  ImPact Biotech to Present at Oppenheimer Private Life Sciences Company Showcase

  September 26, 2024

   · 

  1 min read
• Press Releases

  Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

  September 26, 2024

   · 

  7 min read
• Press Releases

  Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

  September 26, 2024

   · 

  2 min read
• Press Releases

  Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis

  September 26, 2024

   · 

  19 min read